PULMONX CORPORATION
(NASDAQ: LUNG)

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, and Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

9.060

-0.260 (-2.79%)
Range 8.880 - 9.405   (5.91%)
Open -
Previous Close 9.320
Bid Price 12.290
Bid Volume 8
Ask Price 12.290
Ask Volume 10
Volume 174,199
Value -
Remark
Delayed prices. Updated at 17 May 2024 03:59.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis